Geftinat 250mg Tablet: Effective Treatment for Your Condition

Geftinat 250mg Tablet

Uses:

• Treatment of non-small cell lung cancer (NSCLC) in patients where the cancer has spread, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Therapeutic Effects:

• Inhibits an abnormal protein called the epidermal growth factor receptor (EGFR).
• Helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.

Interaction with other drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Geftinat 250mg Tablet and reduce effectiveness by causing undesirable side effects.

Safety Advices:

• Pregnancy: consult your doctor if you are pregnant or planning for pregnancy during the treatment.
• Breastfeeding: it is unsafe to breastfeed during the treatment with this Geftinat 250mg Tablet. Consult your doctor before breastfeeding.
• Lungs: consult your doctor if you have any lung diseases before starting the treatment.
• Liver: inform your physician if you have any liver problems before starting treatment.
• Alcohol: it is unknown whether consuming alcohol interacts with the Geftinat 250mg Tablet. Please consult your doctor for more advice.
• Driving: it is unsafe to drive vehicles or operate heavy machinery after taking the Geftinat 250mg Tablet because it contains a small amount of alcohol which may cause dizziness and impair your concentration.

How to consume:

• The medicine will be prescribed to you by a healthcare professional in a hospital setting.
• This drug is available as a tablet to be taken with or without food, as directed by your healthcare provider.
• The usual recommended dosage is 250 mg tablet once daily.
• Avoid crushing, opening, or dissolving the tablet, swallow it whole with a glass of water.
• Take the Geftinat 250mg tablet at the same time every day.

Side Effects:

• Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, blood in the urine and burning sensation while urinating.

Word of Advice:

• Geftinat 250mg is not recommended for children and adolescents below 18.
• Monitor your blood pressure regularly during this treatment.
• Avoid high-fiber foods and drink lots of fluids if you have severe diarrhea.
• Antacids should not be used two hours before or one hour after taking this tablet.
• Avoid driving and operating heavy machinery if you feel tired or weak during this treatment.

FAQs:

• Q 1. What are the Geftinat 250mg tablet side effects? Diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, nosebleed, blood in the urine and burning sensation while urinating are the common Geftinat 250mg side effects.

• Q 2. Is Geftinat 250mg targeted therapy? Yes, Geftinat 250mg Tablet is a targeted drug therapy that helps to treat advanced non-small-cell lung cancer (NSCLC).

• Q 3. Who should not use Geftinat 250mg tablets? Geftinat 250mg is not indicated for children and adolescents under the age of 18. It should not be used in people who are allergic to this drug, as well as pregnant or breastfeeding women.

• Q 4. Is it safe for women of reproductive potential to use Geftinat 250mg tablets? Geftinat 250mg tablets are not recommended for use during pregnancy and breastfeeding. Tell your healthcare provider before starting this treatment if you are pregnant, think you might be pregnant, breastfeeding, or planning to have a baby.

• Q 5. What should I avoid while taking Geftinat 250mg tablets? It is advised to avoid taking an antacid or stomach acid-reducing medication within two hours before or one hour after taking a Geftinat 250mg tablet.

Fact Box:

• Molecule name: Gefitinib
• Therapeutic class: Antineoplastics
• Pharmacological class: tyrosine kinase inhibitors
• Indications: Non-small cell lung cancer

Tags: cancer_treatment, gefitinib, antineoplastic, drug, tablet, 250mg